SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-049632
Filing Date
2023-06-16
Accepted
2023-06-16 16:01:34
Documents
13
Period of Report
2023-06-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea180489-8k_enzobio.htm   iXBRL 8-K 31295
2 UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION OF THE COMPANY ea180489ex99-1_enzobio.htm EX-99.1 119210
  Complete submission text file 0001213900-23-049632.txt   333324

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE enz-20230616.xsd EX-101.SCH 2944
4 XBRL LABEL FILE enz-20230616_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE enz-20230616_pre.xml EX-101.PRE 22350
7 EXTRACTED XBRL INSTANCE DOCUMENT ea180489-8k_enzobio_htm.xml XML 3477
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 231020855
SIC: 8071 Services-Medical Laboratories